Kulkarni Samarth 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Kulkarni Samarth（CIK 1682019）在 1 家公司共报告 19 笔 SEC Form 4 内部人交易（最近一笔 2026-03-24）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 买入 | 19,687 | $0 |
| 2026-03-24 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 10,020 | $468,736 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 买入 | 20,625 | $0 |
| 2026-03-17 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 10,349 | $499,443 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 买入 | 19,250 | $0 |
| 2026-03-12 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 9,798 | $517,334 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 买入 | 13,250 | $0 |
| 2026-02-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 6,967 | $366,325 |
| 2026-01-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 21,433 | $1.1M |
| 2026-01-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 8,567 | $446,341 |
| 2026-01-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 60,000 | $3.6M |
| 2025-12-22 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 30,000 | $0 |
| 2025-10-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 买入 | 100,000 | $0 |
| 2025-10-20 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 50,895 | $3.5M |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 买入 | 8,334 | $0 |
| 2025-10-15 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 4,242 | $282,517 |
| 2025-09-19 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 6,000 | $0 |
| 2025-08-19 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 买入 | 25,000 | $0 |
| 2025-08-19 | CRISPR Therapeutics AG (CRSP) | Chief Executive Officer | 卖出 | 13,081 | $760,660 |
来源：SEC Form 4 申报文件 · 截至 2026-03-24